Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?

Confalonieri M, Annane D, Antonaglia C, Santagiuliana M, Borriello EM, Meduri GU.

Curr Infect Dis Rep. 2013 Apr;15(2):158-66. doi: 10.1007/s11908-013-0322-8.

PMID:
23371407
2.

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.

Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, Dhainaut JF; PROWESS Clinical Evaluation Committee.

Crit Care Med. 2005 May;33(5):952-61.

PMID:
15891319
3.

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment.

Umberto Meduri G, Bell W, Sinclair S, Annane D.

Presse Med. 2011 Dec;40(12 Pt 2):e543-60. doi: 10.1016/j.lpm.2011.04.023. Epub 2011 Nov 15. Review.

PMID:
22088618
4.

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS.

Crit Care Med. 2009 May;37(5):1594-603. doi: 10.1097/CCM.0b013e31819fb507. Review.

PMID:
19325471
5.

Glucocorticoids and acute lung injury.

Thompson BT.

Crit Care Med. 2003 Apr;31(4 Suppl):S253-7. Review.

PMID:
12682449
6.

Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(10):1-65. Epub 2004 Aug 1.

7.

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

Rello J, Rodriguez A, Lisboa T, Gallego M, Lujan M, Wunderink R.

Crit Care Med. 2009 Feb;37(2):456-62. doi: 10.1097/CCM.0b013e318194b021.

PMID:
19114916
8.

Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.

Yang Y, Xu F, Shi LY, Diao R, Cheng YS, Chen XY, Jing JY, Wang XD, Shen HH.

Chin Med J (Engl). 2012 Feb;125(4):639-45.

9.

[Evaluation of glucocorticoid in treatment for patients with acute respiratory distress syndrome as a result of serious community-acquired pneumonia].

Song ZF, Guo XH, Wang SY, Xie W, Yin N, Zhang Y, Shan HM, Li WH.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Nov;15(11):669-74. Chinese.

PMID:
14604485
11.

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.

PMID:
17095947
12.

Improving outcomes of elderly patients with community-acquired pneumonia.

Gutiérrez F, Masiá M.

Drugs Aging. 2008;25(7):585-610. Review.

PMID:
18582147
13.
14.

Evidence based evaluation of immuno-coagulatory interventions in critical care.

Afshari A.

Dan Med Bull. 2011 Sep;58(9):B4316. Review.

PMID:
21893014
15.

Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose.

Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C.

Ann Intern Med. 2004 Jul 6;141(1):47-56. Review.

PMID:
15238370
16.

Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae.

Vail GM, Xie YJ, Haney DJ, Barnes CJ.

Infection. 2009 Aug;37(4):358-64. doi: 10.1007/s15010-008-8128-6. Epub 2009 Jan 23.

PMID:
19169631
17.

Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia.

Martín-Loeches I, Solé-Violán J, Rodríguez de Castro F, García-Laorden MI, Borderías L, Blanquer J, Rajas O, Briones ML, Aspa J, Herrera-Ramos E, Marcos-Ramos JA, Sologuren I, González-Quevedo N, Ferrer-Agüero JM, Noda J, Rodríguez-Gallego C.

Intensive Care Med. 2012 Feb;38(2):256-62. doi: 10.1007/s00134-011-2406-y. Epub 2011 Nov 24.

PMID:
22113815
18.

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.

Asadi L, Sligl WI, Eurich DT, Colmers IN, Tjosvold L, Marrie TJ, Majumdar SR.

Clin Infect Dis. 2012 Aug;55(3):371-80. doi: 10.1093/cid/cis414. Epub 2012 Apr 16. Review.

19.

Corticosteroid treatment of severe community-acquired pneumonia.

Gorman SK, Slavik RS, Marin J.

Ann Pharmacother. 2007 Jul;41(7):1233-7. Epub 2007 May 22. Review.

PMID:
17519300
20.

Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.

Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA.

Crit Care Med. 1993 Jun;21(6):830-8.

PMID:
8504649
Items per page

Supplemental Content

Write to the Help Desk